Galena Biopharma: Fundamentals Sound Despite SEC Investigation, Maxim Group Says
By Ben Levisohn
Yesterday, Galena Biopharma (GALE) plunged on news that it’s being investigated by the SEC. But at least one analyst believes a little trouble with regulators shouldn’t derail Galena Biopharma’s stock.
Why risk it? Just buy GTHP and sleep well at night and count your gains in the day.
GALE to $3.5+/sh the following day.
Sentiment: Strong Buy